Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Biotechnology|December 18, 2012
Directed evolution of a fluorogen-activating single chain antibody for function and enhanced brightness in the cytoplasmBradley P Yates, Michelle A Peck, Peter B Berget
Biotechnology Journal|July 17, 2009
scFv-based fluorogen activating proteins and variable domain inhibitors as fluorescent biosensor platformsCrystal N Falco, Kaitlyn M Dykstra, Bradley P Yates, et al.
Protein Science : a Publication of the Protein Society|March 10, 2017
Structural and functional characterization of a ubiquitin variant engineered for tight and specific binding to an alpha-helical ubiquitin interacting motifNoah Manczyk, Bradley P Yates, Gianluca Veggiani, et al.
Protein Science : a Publication of the Protein Society|February 23, 2019
Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motifNoah Manczyk, Gianluca Veggiani, Gerald D Gish, et al.
ACS Chemical Biology|April 6, 2022
Panel of Engineered Ubiquitin Variants Targeting the Family of Human Ubiquitin Interacting MotifsGianluca Veggiani, Bradley P Yates, Gregory D Martyn, et al.
Protein Science : a Publication of the Protein Society|November 16, 2018
Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysisGianluca Veggiani, Haiming Huang, Bradley P Yates, et al.
Journal of Molecular Biology|June 6, 2021
Inhibition of Cancer Cell Adhesion, Migration and Proliferation by a Bispecific Antibody that Targets two Distinct Epitopes on αv IntegrinsEugenio Gallo, Abdellali Kelil, Michael Haughey, et al.
ACS Chemical Biology|May 25, 2022
Engineered SH2 Domains for Targeted PhosphoproteomicsGregory D Martyn, Gianluca Veggiani, Ulrike Kusebauch, et al.
Epigenomics|December 23, 2025
Mitochondrial DNA copy number reduction via <i>in vitro TFAM</i> knockout remodels the nuclear epigenome and transcriptomePhyo W Win, Julia Nguyen, Elly H Shin, et al.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Pageof 2